Rare diseases
Investigational molecules
Locations
Back to Germany85 clinical trials in Koblenz, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)GermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyGermanyThe busiest research cities in the country
What the registry says about research in the country
Current clinical trials focus on evaluating novel therapies for both early-stage and metastatic non-small cell lung cancer. Studies are examining innovative treatment combinations and immunotherapy approaches.
Particular emphasis on PD-L1 expression levels and treatment response in various patient populations.
Multiple trials investigating treatments for different breast cancer subtypes, including HER2-negative, triple-negative, and hormone receptor-positive cases.
Focus on personalized treatment strategies and novel drug combinations to improve patient outcomes.
Comprehensive studies examining treatments for various blood cancers, including chronic lymphocytic leukemia, lymphoma, and myelodysplastic syndrome.
Emphasis on targeted therapies and immunotherapy approaches for both adult and pediatric patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
